SD Biosensor, Inc (KRX:137310)
South Korea
· Delayed Price · Currency is KRW 10,150
+110 (1.10%)
At close: Aug 13, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Other Products | 291.53B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Products Growth | 6.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Immunochemical Diagnosis | 149.49B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Immunochemical Diagnosis Growth | -5.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other (Goods, Services, Etc.) | 147.95B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other (Goods, Services, Etc.) Growth | 10.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Self-monitoring of Blood Sugar Level | 78.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Self-monitoring of Blood Sugar Level Growth | 27.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Molecular Diagnostics | 27.43B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Molecular Diagnostics Growth | -1.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Devices Development, Pharmaceutical Development, Raw Material and Compound Manufacturing, and Medical Device Goods | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| In Vitro Dianostics/Molecular | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| In Vitro Dianostics/Molecular Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Blood Sugar | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Blood Sugar Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tuberculosis | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| America | 320.16B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| America Growth | 26.64% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 174.10B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | -10.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | 96.87B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | 7.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | 48.16B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | -34.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India | 34.50B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India Growth | 8.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Africa | 20.78B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Africa Growth | 77.05% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South America | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|